Swedencare AB (SWDCF) Fair Value & Analysis
Consumer Defensive · US · Market cap $500M
Fair value as of: Jun 24, 2026
Analysis
Swedencare AB (SWDCF) currently trades at $3.13, while our model-based Fair Value estimate is $1.65 — implying the stock looks roughly 47.3% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care products, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name. In addition, the company offers dental product for dogs and cats under the ProDen PlaqueO…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Swedencare AB (SWDCF) undervalued?
What is the fair value of SWDCF?
What is the quality score of SWDCF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.